Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of the Touro College & University System, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to Scholarly Communications Librarian Donneer Missouri.

Total number of publications: 7,082

Enter a faculty name:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

First Prev 1 2 3 4 5 6 7 8 9 10 Next Last
  • Abraham, W. T., Burkhoff, D., Nademanee, K., Carson, P., Bourge, R., Ellenbogen, K. A., . . . Kadish, A. H. (2008). A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: Rationale, design, and baseline patient characteristics. American Heart Journal, 156(4), 641-648.e1. This material can be found here.

  • Ahmed, M. W., Kadish, A. H., Parker, M. A., & Goldberger, J. J. (1994). Effect of physiologic and pharmacologic adrenergic stimulation on heart rate variability. Journal of the American College of Cardiology, 24(4), 1082-1090. This material can be found here.

  • Al-Khatib, S. M., Han, J. Y., Edwards, R., Bardy, G. H., Bigger, J. T., Buxton, A. E., . . . Kadish, A. H. (2014). Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator? International Journal of Cardiology, 172(1), 253-254. doi:10.1016/j.ijcard.2013.12.278

  • Altura, B. M., Gebrewold, A., Shah, N. C., Shah, G. J., & Altura, B. T. (2016). Potential roles of magnesium deficiency in inflammation and atherogenesis: Importance and cross-talk of platelet-activating factor and ceramide. Journal of Clinical & Experimental Cardiology, 7 [Article 427]. doi:10.4172/2155-9880.1000427

  • Altura, B. M., Li, W., Zhang, A., Zheng, T., Shah, N. C., Shah, G. J., . . . Altura, B. T. (2016). Sudden cardiac death in infants, children and young adults: Possible roles of dietary magnesium intake and generation of platelet-activating factor in coronary arteries. Journal of Heart Health, 2(2). doi:10.16966/2379-769X.121

  • Altura, B. M., Li, W., Zhang, A., Zheng, T., Shah, N. C., Shah, G. J., . . . Altura, B. T. (2016). The expression of platelet-activating factor is induced by low extracellular Mg2+ in aortic, cerebral and neonatal coronary vascular smooth muscle; cross talk with ceramide production, NF–kB and proto-oncogenes: Possible links to atherogenesis and sudden cardiac death in children and infants, and aging: Hypothesis, review and viewpoint. International Journal of Cardiology and Research, 3(1), 47-67. This material can be found here.

  • Altura, B. M., Shah, N. C., Shah, G. J., & Altura, B. T. (2016). Genotoxic effects of magnesium deficiency in the cardiovascular system and their relationships to cardiovascular diseases and atherogenesis [Special issue]. Journal of Cardiovascular Diseases & Diagnosis, S1 [Article 008]. This material can be found here.

  • Altura, B. M., Shah, N. C., Shah, G. J., Pérez-Albela, J. L., & Altura, B. T. (2016). Insights into the possible mechanisms by which platelet-activating factor and PAF-receptors function in vascular smooth muscle in magnesium deficiency and vascular remodeling: Possible links to atherogenesis, hypertension and cardiac failure. International Journal of Cardiology and Research, 3(1e), 1-3. This material can be found here.

  • Altura, B. M., Shah, N. C., Shah, G. J., Pérez-Albela, J. L., & Altura, B. T. (2016). Magnesium deficiency results in oxidation and fragmentation of DNA, down regulation of telomerase activity, and ceramide release in cardiovascular tissues and cells: Potential relationship to atherogenesis, cardiovascular diseases and aging. International Journal of Diabetology & Vascular Disease Research, 4(1e), 1-5. This material can be found here.

  • Altura, B. M., Shah, N. C., Shah, G. J., Perez-Albela, J. L., & Altura, B. T. (2016). Why is postoperative atrial fibrillation difficult to prevent and treat: Potential roles of unrecognized magnesium deficiency and release of ceramide and platelet-activating factor. International Journal of Surgery and Research, 3(3), 47-51. This material can be found here.

  • Altura, B. M., Shah, N. C., Shah, G. J., Zhang, A., Li, W., & Altura, B. T. (2016). Is the high frequency of postoperative atrial fibrillation after cardiac and lung surgeries related to hypomagnesemia and releases of ceramides and platelet-activating factor? Clinics in Surgery, 1 [Article 1140]. This material can be found here.

  • Amar, D., Zhang, H., Miodownik, S., & Kadish, A. H. (2003). Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. Journal of the American College of Cardiology, 42(7), 1262-1268. doi:10.1016/S0735-1097(03)00955-0

  • Amar, S., Wu, S. C., & Madan, M. (2009). Is porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications. Journal of Immunology, 182(3), 1584-1592. This material can be found here.

  • Arora, R., Ulphani, J. S., Villuendas, R., Ng, J., Harvey, L., Thordson, S., . . . Kadish, A. H. (2008). Neural substrate for atrial fibrillation: Implications for targeted parasympathetic blockade in the posterior left atrium. American Journal of Physiology: Heart & Circulatory Physiology, 294(1), H134-144. doi:10.1152/ajpheart.00732.2007

  • Arora, R., Villuendas, R., Ng, J., Goldstein, J., Mottl, S., Goldberger, J. J., . . . Kadish, A. H. (2007). Targeted G-protein inhibition in the posterior left atrium: A novel method to selectively inhibit parasympathetic signaling in the left atrium [Supplemental material]. Heart Rhythm, 4(5), S9-S10.

  • Ayzman, I., Dibs, S., Goldberger, J. J., Passman, R., & Kadish, A. H. (2002). In vitro performance characteristics of reused ablation catheters. Journal of Interventional Cardiac Electrophysiology, 7(1), 53-59. doi:10.1023/A:1020820200112

  • Bansal, N., Szpiro, A., Masoudi, F., Greenlee, R. T., Smith, D. H., Magid, D. J., . . . Kadish, A. H. (2017). Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Heart, 103(7), 529-537. This material can be found here.

  • Banthia, S., Bergner, D. W., Chicos, A. B. , Ng, J., Pelchovitz, D. J., Subacius, H., . . . Kadish, A. H. (2013). Detection of cardiovascular autonomic neuropathy using exercise testing in patients with type 2 diabetes mellitus. Journal of Diabetes and Its Complications, 27(1), 64–69. doi: 10.1016/j.jdiacomp.2012.09.002

  • Bello, D., Kaushal, R., Fieno, D. S., Goldberger, J. J., Shivkumar, K., & Kadish, A. H. (2005). Cardiac MRI: Detection of myocardial infarction in symptomatic patients without coronary artery disease undergoing electrophysiological testing [Supplemental material]. Heart Rhythm, 2(5), S148. doi:10.1016/j.hrthm.2005.02.464

  • Belperio, J., Horwich, T., Abraham, W. T., Fonarow, G. C., Gorcsan, J., III, Bersohn, M. M., . . . Kadish, A. H. (2016). Inflammatory mediators and clinical outcome in patients with advanced heart failure receiving cardiac resynchronization therapy. American Journal of Cardiology, 117(4), 617-625. doi:10.1016/j.amjcard.2015.11.049

  • Bennett, W., Lombardi, D., Eisenhart, A., Acosta, J., Cerbone, D., McCoy, L., & Yens, D. P. (2008). Risk factors for acute myocardial infarction in our patient population: A retrospective pilot study. New York Medical Journal, 3(2). This material can be found here.

  • Bergeron, N., Phan, B. A., Ding, Y., Fong, A., & Krauss, R. M. (2015). Proprotein convertase subtilisin/kexin type 9 inhibition: A new therapeutic mechanism for reducing cardiovascular disease risk. Circulation, 132(17), 1648-1666. doi:10.1161/CIRCULATIONAHA.115.016080

  • Boekholdt, S. M., Arsenault, B. J., Hovingh, G. K., Mora, S., Pedersen, T. R., LaRosa, J. C., . . . Clearfield, M. (2013). Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: A meta-analysis. Circulation, 128(14), 1504-1512.  doi:10.1161/CIRCULATIONAHA.113.002670

  • Boekholdt, S. M., Arsenault, B. J., Mora, S., Pedersen, T. R., LaRosa, J. C., Nestel, P. J., . . . Clearfield, M. B. (2012). Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: A meta-analysis. JAMA, 307(12), 1302-1309. doi:10.1001/jama.2012.366

  • Boekholdt, S. M., Hovingh, G. K., Mora, S., Arsenault, B. J., Amarenco, P., Pedersen, T. R., . . . Clearfield, M. B. (2014). Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: A meta-analysis of statin trials. Journal of the American College of Cardiology, 64(5), 485-494. doi:10.1016/j.jacc.2014.02.615

First Prev 1 2 3 4 5 6 7 8 9 10 Next Last